Dec 8 (Reuters) - Structure Therapeutics said on Monday that its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study. Analysts, including those at BMO ...
GLP-1 RAs are safe and efficacious for adults with IBD, with no increased risk for flare-ups, hospitalization, corticosteroid use, or operation.
Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related ...
A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 ...
Wellbeing Whisper on MSN
Hidden dangers of GLP‑1 weight‑loss drugs you need to know
What if the race to get thin was quietly putting health at risk? That question is becoming harder to ignore as glucagon‑like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback